US Stock MarketDetailed Quotes

McKesson (MCK)

Watchlist
  • 820.230
  • +3.180+0.39%
Close Jan 23 16:00 ET
  • 820.230
  • 0.0000.00%
Post 20:01 ET
101.24BMarket Cap25.64P/E (TTM)

About McKesson Company

McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs. The RxTS segment offers prescription price transparency, benefit insight, dispensing support services, third-party logistics, and wholesale distribution. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The International segment refers to the distribution and services to wholesale, institutional, and retail customers in Europe and Canada. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.

Company Profile

SymbolMCK
Company NameMcKesson
Listing DateAug 24, 1994
ISINUS58155Q1031
Founded1833
CEODr. Brian S. Tyler,PhD
MarketNYSE
Employees45000
Fiscal Year Ends03-31
Address6555 State Highway 161
CityIrving
ProvinceTexas
CountryUnited States of America
Zip Code75039
Phone1-972-446-4800

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Brian S. Tyler,PhD
  • Director and Chief Executive Officer
  • 20.16M
  • Michele Lau
  • Executive Vice President and Chief Legal Officer
  • 5.23M
  • LeAnn B. Smith
  • Executive Vice President and Chief Human Resources Officer
  • 3.72M
  • Thomas L. Rodgers
  • Executive Vice President, Chief Strategy and Business Development Officer
  • 3.21M
  • Britt J. Vitalone
  • Executive Vice President and Chief Financial Officer
  • 7.68M
  • Napoleon B. Rutledge, Jr
  • Senior Vice President, Controller and Principal Accounting Officer
  • --
  • Donald R. Knauss
  • Chairman of the Board
  • 593.99K
  • Maria N. Martinez
  • Independent Director
  • 353.67K
  • Lynne M. Doughtie
  • Independent Director
  • 123.84K
  • Kathleen Wilson-Thompson
  • Independent Director
  • 338.67K
  • W. Roy Dunbar
  • Independent Director
  • 333.67K
  • Kevin M. Ozan
  • Independent Director
  • 348.67K
  • James H. Hinton
  • Independent Director
  • 333.67K
  • Dominic J. Caruso
  • Independent Director
  • 358.67K
  • Bradley E. Lerman
  • Independent Director
  • 353.67K
  • Dr. Julie L. Gerberding, M.D.,M.P.H.
  • Independent Director
  • 123.84K
  • Dr. Deborah L. Dunsire,M.D.
  • Independent Director
  • 345.96K
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More